Staff & Members
About PRIME-TR
PRIME-TR aims to be a pioneer in transforming cancer therapy through the modulation of the human microbiome. Our mission is to build a robust framework that enables a concerted effort for translational research by leveraging existing resources at our institution and by developing programs and relationships to support novel translational applications. Our ultimate goal is to improve prevention, diagnosis and treatment strategies for cancer patients and the population at-risk. Succeeding at this vision would result in the ability to prevent and treat a wider population via novel and better strategies based on microbiome applications. Our program is envisioned to grow to a self-sustainable and dedicated team to promote and support translational microbiome research within MD Anderson.
Core Staff
Jennifer A. Wargo, M.D., M.M.S.c.
Program Director
jwargo@mdanderson.org
Nadim Ajami, Ph.D.
Executive Director for Scientific Research
NAjami@mdanderson.org
Samuel Shelburne, M.D., Ph.D.
Co-Director
Robert Jenq, M.D.
Co-Director
Christine Diaz
Program Manager
cmdiaz1@mdanderson.org
Andreeka Lewis
Sr. Administrative Assistant
AJLewis1@mdanderson.org
Matthew Wong
Sr. Scientific Applications Specialist
mcwong@mdanderson.org
Pranoti Sahasrabhojane
Supervisor Clinical Studies
PVSahasrabhojane@mdanderson.org
Khalel Imanbayev, M.D.
Research Data Coordinator
KImanbayev@mdanderson.org
Affiliated Members
Alexander Lazar, M.D., Ph.D.
Pathology Lead
Christine Peterson, Ph.D.
Biostatistics Lead
Carrie Daniel-MacDougall, Ph.D.
Nutritional and Epidemiology Lead
Crisy Roland, M.D.
Clinical Trials lead
Stephanie Watowich, Ph.D.
Immunology lead
Florencia McAllister, Ph.D.
Preclinical Testing lead
Vanessa Jensen, D.V.M.
Animal Models Lead